Complicated UTI Chronicles: Twists & Turns

Rachel Beatty, APRN

The Infectious Diseases Society of America (IDSA) has recently released updated guidelines and management for complicated urinary tract infections (cUTIs). These guidelines represent IDSA’s first dedicated cUTI guidance covering both men and women.

This marks a major scope expansion from previous UTI-focused guidelines. Clinical decision making is now centered around clinical presentation and lab-informed risk, rather than outdated anatomy-based definitions. New guidance includes empiric antibiotic decision trees, updated treatment durations, and protocols for moving from IV to oral therapy.

New Classifications

Uncomplicated UTIs are defined as infections limited to the bladder in men and women without fevers.

Complicated UTIs are infections beyond the bladder. These include pyelonephritis, febrile or bacteremic UTIs, catheter-associated infections, and prostatitis.

Complicated UTI Classifications (For Guideline Purposes)

Type	Clinical Features
General cUTI	Fever Systemic symptoms (chills, rigors, hemodynamic instability) Flank pain Costovertebral angle tenderness (CVAT)
Pyelonephritis	Presence of infection extending to the kidney
Catheter-related	Symptoms with transurethral, suprapubic, or intermittent catheter use
Special Populations	Indwelling catheter, urinary retention or obstruction, neurogenic bladder

Uncomplicated UTI Classifications (For Guideline Purposes)

Type	Clinical Features
Uncomplicated UTI	Confined to bladder Dysuria, urgency, frequency, suprapubic pain No fever, flank pain, CVAT, or systemic illness

Antibiotic Recommendations for Complicated UTIs

Antibiotic choice should be ranked in the following priority:

Severity of illness
Risk for antibiotic resistance
Patient-specific considerations
Presence of sepsis

Empiric Antibiotics for cUTIs

Scenario	Recommended Antibiotics	Alternative Options
Sepsis or risk of sepsis	3rd/4th gen cephalosporins Carbapenems Piperacillin-tazobactam Fluoroquinolones	Novel β-lactam/β-lactamase inhibitors Cefiderocol Plazomicin Aminoglycosides
Non-septic (IV Therapy)	3rd/4th gen cephalosporins Piperacillin-tazobactam Fluoroquinolones	Carbapenems Novel β-lactam/β-lactamase inhibitors Cefiderocol Aminoglycosides
Non-septic (Oral Therapy)	Fluoroquinolones Trimethoprim-sulfamethoxazole (TMP-SMX)	Amoxicillin-clavulanate Oral cephalosporins

IV and Oral Therapy Dosing

Oral Antibiotic Characteristics for cUTI Treatment

Drug	Oral Absorption (%)	Urinary Excretion (%)	Recommended Dose (Normal Renal Function)
Amoxicillin-clavulanate	80% (amoxicillin) Variable (clavulanate)	50-70% (amoxicillin) 25-40% (clavulanate)	875mg/125mg every 8 to 12 hours Other regimens may be more effective
Cefixime	50%	50%	400mg once daily
Cefpodoxime	50%	80%	200mg to 400mg every 12 hours
Cefibuten	75-90%	73%	9mg/kg daily (children) 400mg daily or 200mg every 12 hours (adults)
Cefuroxime	52%	90%	500mg every 12 hours
Cephalexin	90%	90%	500mg to 1000mg every 6 hours Other regimens may be more effective
Ciprofloxacin	70%	40-50%	500mg to 750mg every 12 hours
Levofloxacin	99%	64-100%	500mg to 750mg daily
Other oral beta-lactams (e.g. amoxicillin, cefadroxil, cefaclor, cefdinir)	Comparative clinical outcomes data versus highly bioavailable oral alternatives are more limited and/or discouraging; consider use with infectious disease pharmacist consultation if alternatives are not available.
Trimethoprim-sulfamethoxazole	70-90%	84% (sulfamethoxazole) 66% (trimethoprim)	800mg/160mg every 12 hours

IV Antibiotic Dosing for Complicated UTI

Based on clinical studies for patients with normal renal function

Drug	Dosing Regimen
Cefepime	1-2g every 8 to 12 hours
Cefepime-enmetazobactam	2g/0.5g (infused over 2 hours) every 8 hours
Cefiderocol	2g (infused over 3 hours) every 8 hours
Cefotaxime	1-2g every 8 hours
Ceftazidime	1-2g every 8 hours
Ceftazidime-avibactam	2.5g (infused over 2 hours) every 8 hours
Ceftolozane-tazobactam	1.5g every 8 hours
Ceftriaxone	1-2g daily
Ertapenem	1g daily
Fosfomycin	6g every 8 hours
Imipenem-cilastatin	500mg every 6 hours 1g every 8 hours
Imipenem-cilastatin-relebactam	500mg/125mg every 6 hours
Meropenem	1g every 8 hours
Meropenem-vaborbactam	2g/2g (infused over 3 hours) every 8 hours
Piperacillin-tazobactam	4.5g every 8 hours
Plazomicin	10-15mg/kg daily

Note: This table includes IV dosing for cUTI based on review of randomized controlled trials among patients with complicated UTI.

Other Considerations in Practice

Discontinue broad-spectrum therapy once cultures return and tailor to susceptibilities.
Switch from IV to oral therapy when clinical improvement is observed.
Outpatient oral antibiotics are acceptable for stable patients without sepsis.
High-risk patients (e.g., diabetics, immunocompromised) do not automatically meet cUTI criteria but warrant close follow-up.
Always consider acute prostatitis in men presenting with UTI symptoms—it may require a different treatment pathway.
Lack of improvement? Reassess with local antibiogram and resistance patterns.

Takeaway / Summary

The 2025 IDSA cUTI guidelines reflect a shift toward rational, symptom-based, antibiotic stewardship-conscious management. For the first time, men are included in classification. Empiric treatment follows a four-step approach: illness severity, resistance risk, patient factors, and sepsis. Many patients can be treated effectively with oral therapy in outpatient settings, and conversion from IV to oral should be started as soon as deemed appropriate.

To further enhance your clinical skills in managing complicated conditions like UTIs and more, consider attending the Clinical Skills and Procedure Workshop offered by Provider Practice Essentials. This hands-on program is ideal for building competence in procedures, diagnostics, and critical decision-making—perfect for providers managing patients with complex infections.

👉 Learn more and register here: Clinical Skills and Procedure Workshop

References

Infectious Diseases Society of America. (July 2025). Complicated urinary tract infections. Retrieved from https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/

National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Urinary tract infections – UTI symptoms. MedlinePlus. Retrieved from https://medlineplus.gov/urinarytractinfections.html

Mayo Clinic. (n.d.). Urinary tract infection (UTI): Symptoms and causes. Mayo Clinic. Retrieved from https://www.mayoclinic.org/diseases-conditions/urinary-tract-infection/symptoms-causes/syc-20353447

Rachel Beatty, APRN, FNP-C, ACGN-BC

Mrs. Beatty received her Bachelor’s of Science in Nursing from Adventist University in Orlando, Florida. She Earned her Master of Science in Nursing from the University of South Alabama, graduating in the top 10% of her class. She is a member of the Phi Kappa Phi Honor Society and has an extensive background in clinical nursing education. She has earned dual board certification as a family nurse practitioner and an adult/geriatric acute care nurse practitioner from the American Nurses Credentialing Center (ANCC). As a former nurse in emergency medicine, she earned her certification as an emergency nurse, and has successfully transitioned her broad-based clinical knowledge to the private practice setting as a family practice nurse practitioner and an urgent care nurse practitioner. With experience in both the outpatient and acute care settings, Mrs. Beatty is well prepared to educate nurse practitioners and physician assistants about current topics in clinical management and the expectations of modern care delivery.